227 related articles for article (PubMed ID: 28602703)
21. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
[TBL] [Abstract][Full Text] [Related]
23. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia.
Fraenkel-Wandel Y; Raveh-Brawer D; Wiener-Well Y; Yinnon AM; Assous MV
J Antimicrob Chemother; 2016 Apr; 71(4):1083-7. PubMed ID: 26661396
[TBL] [Abstract][Full Text] [Related]
24. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.
Navarro-San Francisco C; Mora-Rillo M; Romero-Gómez MP; Moreno-Ramos F; Rico-Nieto A; Ruiz-Carrascoso G; Gómez-Gil R; Arribas-López JR; Mingorance J; Paño-Pardo JR
Clin Microbiol Infect; 2013 Feb; 19(2):E72-9. PubMed ID: 23231088
[TBL] [Abstract][Full Text] [Related]
25. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
[TBL] [Abstract][Full Text] [Related]
26. Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla
Xu M; Fu Y; Kong H; Chen X; Chen Y; Li L; Yang Q
BMC Infect Dis; 2018 Jul; 18(1):358. PubMed ID: 30064360
[TBL] [Abstract][Full Text] [Related]
27. The risk factors for complications and survival outcomes of Klebsiella pneumoniae Bacteraemia in Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia.
Ang SH; Petrick P; Shamsul AS; Ramliza R; Kori N; Lau CL
Med J Malaysia; 2022 Jul; 77(4):440-445. PubMed ID: 35902933
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center.
Filozov A; Visintainer P; Carbonaro C; Aguero-Rosenfeld M; Wormser GP; Montecalvo MA
Am J Infect Control; 2009 Nov; 37(9):723-8. PubMed ID: 19501935
[TBL] [Abstract][Full Text] [Related]
30. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Lee CH; Su LH; Tang YF; Liu JW
J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care.
Tseng CP; Wu HS; Wu TH; Lin YT; Fung CP
J Microbiol Immunol Infect; 2013 Jun; 46(3):217-23. PubMed ID: 22832028
[TBL] [Abstract][Full Text] [Related]
32. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.
Freire MP; Abdala E; Moura ML; de Paula FJ; Spadão F; Caiaffa-Filho HH; David-Neto E; Nahas WC; Pierrotti LC
Infection; 2015 Jun; 43(3):315-23. PubMed ID: 25690848
[TBL] [Abstract][Full Text] [Related]
34. High mortality associated with inappropriate initial antibiotic therapy in hematological malignancies with Klebsiella pneumoniae bloodstream infections.
Ma Z; Lai C; Zhang J; Han Y; Xin M; Wang J; Wu Z; Luo Y
Sci Rep; 2024 Jun; 14(1):13041. PubMed ID: 38844581
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.
Corcione S; Angilletta R; Raviolo S; Filippini C; Fossati L; Di Perri G; Cavallo R; De Rosa FG
Eur J Intern Med; 2018 Feb; 48():44-49. PubMed ID: 29096992
[TBL] [Abstract][Full Text] [Related]
36. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
Liu SW; Chang HJ; Chia JH; Kuo AJ; Wu TL; Lee MH
J Microbiol Immunol Infect; 2012 Apr; 45(2):113-9. PubMed ID: 22154994
[TBL] [Abstract][Full Text] [Related]
37. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
Lee JA; Kang CI; Joo EJ; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Ko KS; Lee NY; Song JH
Microb Drug Resist; 2011 Jun; 17(2):267-73. PubMed ID: 21388296
[TBL] [Abstract][Full Text] [Related]
39. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.
Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M
J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.
Chen J; Li J; Huang F; Fang J; Cao Y; Zhang K; Zhou H; Cai J; Cui W; Chen C; Zhang G
BMC Pulm Med; 2023 Mar; 23(1):102. PubMed ID: 36978069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]